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C l i n i c a l Reports
The Exclusion of Restrictive Lung Disease by Spirometric
Criteria in Patients with a Reduced Forced Vital Capacity
Michael S. Eichenhorn, MD,* John Popovich, Jr, MD,*
Richard K. Beauchamp, R-CPT, John Armstrong, MD, and Joseph C . Ward, MD*

Reductions in forced vital capacity (EVC) as determined
by spirometry may result from restrictive or obstructive
disease, either alone or in combination. Restrictive disease is impUed when measures of forced expiratory flow
are relatively maintained,
and obstructive
disease is
present when flow measurements are
disproportionately reduced. In the presence of air flow
obstruction,
the possibiUty of concomitant restrictive disease contributing to the reduction in FVC is difficult to assess from
spirometry alone. Static lung volumes are usually necessary to establish this diagnosis.

We evaluated the FEV-,/EVC%o obtained at spirometry
compared to its predicted normal value. We found it to
be useful in eliminating the need for additional testing in
many cases in which the question of mixed
obstructive
and restrictive disease had been raised. Specifically, in
patients with obstructive disease and a reduced FVC,
an FEV-i/FVC% of less than 81%, of the age-, height-, and
sex-matched predicted value largely excluded the possibility that concomitant restrictive disease was also present (p<.05). Higher values had no predictive value.

T h e patient's forced vital capacity (FVC) as determined
by spirometry may be reduced as a result of obstructive
or restrictive lung disease or combinations of these two
conditions. Poor terminal effort by the patient may also
reduce the FVC, but this can usually be recognized by
visual inspection of the spirometric tracing. Obstructive
disease is considered to be present when the reduction
in forced expiratory volume in one second (FEV) is
greater than the reduction in FVC, i.e., the FEVi/FVC% is
decreased. Obstructive disease is also present when the
forced mid-expiratory flow (FEFjs./s) is reduced, even if
the FEVi/FVC% is maintained. It is, however, not likely
that air flow obstruction confined to the peripheral airways as manifested by reductions in terminal flow could
result in reductions in forced vital capacity (1). Restrictive disease may be implied f r o m the spirogram when
the FEVi/FVC% and FEF25.75 are maintained despite the
reduction in FVC, although total lung capacity (TLC)
must be reduced to less than 80% of its predicted value
to establish this diagnosis definitely (2).

whether some element of restrictive disease is also present. While visual inspection of simultaneous flow volume
curves may provide some information, this method is
not exact and requires extra technical apparatus. If a
method could be devised that w o u l d permit the clinician to accurately diagnose restrictive lung disease f r o m
the spirogram in these situations, it w o u l d help eliminate
concern about the existence of concomitant unsuspected disease. It w o u l d also save the pulmonary laboratory f r o m performing unnecessary static lung volume
determinations. We have found the FEV/FVC% as c o m pared to its predicted value to be useful in this regard.

Methods
We reviewed studies of all patients referred to the Pulmonary Function Laboratory for testing in two consecu-
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When the FVC and FEV/FVC% are both markedly reduced,
it is difficult to determine f r o m the spirogram alone
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tive years. From 4,240 studies, 435 patients were identified with airflow obstruction and a reduced FVC (less
than 80% predicted), for w h o m static lung volumes by
plethysmography were also performed at the same sitting. Patients with reductions in the FEV/FVC% below
that predicted for their height and age (by Morris's
standards) (3) were considered to have air flow obstruction. Patients with a TLC less than 80% of predicted
(Goldman's standards) (4) were classified as restricted. In
addition to routine spirometric analysis, we also calculated the ratio of the FEV, to the FVC actually obtained to
that predicted. We then performed discriminant analysis
of the above data.

Results
Patients ranged in age f r o m 11-89 years, with a mean age
of 55.3 years. There were 264 men and 171 w o m e n . Of
435 patients, 344 had a normal or elevated total lung
capacity, while 91 were restricted as defined above (Fig.
1). We then applied parametric discriminant analysis to
this population using the methodology of Mardi a (5) and
Morrison (6). In these patients with a reduced FVC, Xi
was assigned to the mean FEV/FVCX of predicted for
those patients with a TLC <80% of predicted, and x^
represented the FEVi/FVC% of predicted for those with
a TLC >80% of predicted. Statistical analysis could then
be determined; the cut-off point was one half (x, + x,).

and an associated variance was equal to one fourth (var
Xi + Xj). This revealed an estimated cut-off point of 0.81 at
a 95% confidence level and a standard error of 0.01.
Hence, when the FEVi/FVC% was less than 8 1 % of predicted, only 7% (17/228) of our patients had a reduced
TLC. W h e n the FEV/FVC% was greater than 8 1 % of
predicted, no clearcut discrimination could be made
between those with or w i t h o u t concomitant restrictive
disease.
We then studied the 17 cases which had low TLC values
despite an FEVi/FVC% less than 8 1 % of predicted. Unfortunately, the records of three patients could not be
located. Two other patients had diagnoses of " o l d
tuberculosis," but their records did not contain enough
information to deduce the extent of such disease.
A definitive cause for restrictive disease could be found
in each of the remaining 12 cases. Four patients had
roentgenographic evidence of significant prior granulomatous disease, with a thoracoplasty in one case, a
thoracoplasty and phrenic nerve section in one case,
extensive pleural and parenchymal scarring in one case,
and prior left upper lobectomy and complicating aspergilloma in one case. Three patients had carcinoma; one
had a six cm right upper lobe mass together with a large
right pleural effusion and interstitial infiltrates compatible with lymphangitic spread, while two others had
undergone earlier lobectomies for cancer. O n e additional patient had undergone earlier resection for bullous emphysema, with prominent areas of persistent
bullous change still evident.
Four remaining patients had widespread parenchymal
disease by clinical and roentgenographic analysis sufficient to account for the observed reductions in TLC.
There was one case each of Stage III sarcoidosis, c o n glomerate silicosis, Wegener's granulomatosis w i t h
extensive reticulonodular infiltrates, and sickle cell
anemia with repeated pneumonias and pulmonary infarcts
resulting in extensive fibrotic changes bilaterally.

Discussion
Spirometry remains a useful screening test for p u l m o nary disease. Reductions in forced expiratory flow rates
establish the presence of air flow obstruction, while
maintenance of flow rates together with reductions in
FVC imply a restrictive process. This latter diagnosis can
be established only when TLC as judged by static lung
volume measurements is also reduced. As air flow
obstruction worsens, the FVC may also fall as a result of
air trapping. In the presence of severe obstructive disease and a reduced FVC, it is often difficult to determine
whether some element of restrictive disease is also pres-

Fig. 1
FEViFVC% (actual/predicted) vs total lung capacity (TLC).
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ent. We have f o u n d the FEVi/FVC% to be a useful index
in excluding, with a relatively high degreeof certainty, a
concomitant restrictive disorder in this subset of patients,
based on spriometric analysis alone. As expected, as the
FEVi/FVC% decreased, there was a greater tendency
toward hyperinflation as manifested by increasing lung
volumes (R = .65). In fact, as shown by parametric discriminant analysis, when the FEVi/FVC% was less than or
equal to 8 1 % of predicted, only 7% of patients had a total
lung capacity of less than 80%. O f the 17 cases with
restrictive lung disease in addition to air flow obstruction and a low FEVi/FVC%, clinical and roentgenographic evaluation disclosed a definite cause for restrictive disease in the 12 (100%) patients for w h o m we had
adequate clinical and roentgenographic data.

tive disease from spirometry alone. It is particularly valuable in the presence of airflow obstruction when the
FVC may be markedly reduced. Thus, when airflow
obstruction is most severe, concomitant restrictive disease is highly unlikely, even in the presence of a reduced
FVC, unless strong clinical a n d / o r roentgenographic
evidence indicates its presence. This finding counters
the c o m m o n clinical spirometric interpretation, which
may often suggest mixed restrictive and obstructive disease. When airflow obstruction is less severe, spirometry
provides little discrimination. The use of the FEVi/FVC%
provides the clinician w i t h a reasonable means of predicting static lung volume determinations without requiring their actual performance. The reassurance provided
by this measurement together with the associated savings in cost should reinforce the utility of this ratio as a
routine spirometric calculation.

Thus, the FEVi/FVC% as compared to its predicted value
provides a useful, accurate means of detecting restric-
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Invasive O f i f i s E x t e r n a
In 1959, an elderly diabetic man died from a pseudomonas osteomylitis of the mandible and zygoma. Ten years
later 13 patients were reported w h o had an external
otitis following pseudomonas infections which spread to
the adjacent soft tissues and bony structures o f t h e skull.
Becauseof the severity of the infection and its indolently
invasive course, the term "malignant otitis externa" was
coined. Recently an extensive review added another 21
cases, and the t e r m , invasive external otitis, was suggested. (Doroghazi R M , Nadol JB, Hyslop NE, Baker AS,
Axelrod L. Invasive external otitis: Report of 21 cases and
review of the literature. Am J M e d 1981;71:603-14).
Unilateral aural pain, ear canal drainage, local granulation tissue, and occasionally a perforated tympanic
membrane occur. A persistent infection may extend to
the soft tissues and bony structures adjacent to the ear
canal. Cranial nerve palsies, especially the facial, are
present in one of three patients. The facial nerve palsy is

usually permanent. Ninety percent of the patients with
invasive external otitis are elderly diabetics, and men
predominately. Pseudomonas aeruginosa is uniformly
cultured. Although the pathogenesis is poorly understood, local diabetic microangiopathy and poor local
tissue perfusion seem to favor the spread of the pseudomonas infection.
Recognition and early diagnosis are mandatory. Successful therapy includes a three-to-six-week parenteral course
of an aminoglycoside (tobramycin or gentamicin) and a
semisynthetic penicillin (ticarcillin or carbencillin). Surgical treatment is required when soft and bony tissue
involvement is extensive. Mortality may be 15%.
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